Fred E Cooperrider

Array ( [id] => 3853208 [patent_doc_number] => 05767258 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Cell cycle regulatory gene' [patent_app_type] => 1 [patent_app_number] => 8/439962 [patent_app_country] => US [patent_app_date] => 1995-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 14465 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767258.pdf [firstpage_image] =>[orig_patent_app_number] => 439962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3853294 [patent_doc_number] => 05767263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Base-modified enzymatic nucleic acid' [patent_app_type] => 1 [patent_app_number] => 8/435521 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 11379 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767263.pdf [firstpage_image] =>[orig_patent_app_number] => 435521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011421 [patent_doc_number] => 05879938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Base-modified enzymatic nucleic acid' [patent_app_type] => 1 [patent_app_number] => 8/435398 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 11393 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879938.pdf [firstpage_image] =>[orig_patent_app_number] => 435398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648988 [patent_doc_number] => 05605830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Murine and human c-Myc interacting protein' [patent_app_type] => 1 [patent_app_number] => 8/435454 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6778 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605830.pdf [firstpage_image] =>[orig_patent_app_number] => 435454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854832 [patent_doc_number] => 05705359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Expression of heterologous proteins in drosophila cells' [patent_app_type] => 1 [patent_app_number] => 8/434095 [patent_app_country] => US [patent_app_date] => 1995-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10727 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705359.pdf [firstpage_image] =>[orig_patent_app_number] => 434095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3631011 [patent_doc_number] => 05686599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Synthesis, deprotection, analysis and purification of RNA and ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/432876 [patent_app_country] => US [patent_app_date] => 1995-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 22 [patent_no_of_words] => 12255 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686599.pdf [firstpage_image] =>[orig_patent_app_number] => 432876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272534 [patent_doc_number] => 06323184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Arteriovenous and venous graft treatments: methods and compositions' [patent_app_type] => 1 [patent_app_number] => 8/424991 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 58 [patent_no_of_words] => 21268 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323184.pdf [firstpage_image] =>[orig_patent_app_number] => 424991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693121 [patent_doc_number] => 05676952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Herpesviruses transformed to express GD in vitro' [patent_app_type] => 1 [patent_app_number] => 8/426020 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6696 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/676/05676952.pdf [firstpage_image] =>[orig_patent_app_number] => 426020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727374 [patent_doc_number] => 05652117 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Human transcription factor IIA' [patent_app_type] => 1 [patent_app_number] => 8/411635 [patent_app_country] => US [patent_app_date] => 1995-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10058 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652117.pdf [firstpage_image] =>[orig_patent_app_number] => 411635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3754553 [patent_doc_number] => 05851519 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Live vaccines' [patent_app_type] => 1 [patent_app_number] => 8/419618 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3892 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851519.pdf [firstpage_image] =>[orig_patent_app_number] => 419618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217932 [patent_doc_number] => 06040159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'TNF-.alpha. ribozymes and derivatives capable of decreasing degradation of MRNA in vivo' [patent_app_type] => 1 [patent_app_number] => 8/416516 [patent_app_country] => US [patent_app_date] => 1995-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 9824 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040159.pdf [firstpage_image] =>[orig_patent_app_number] => 416516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646706 [patent_doc_number] => 05683902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Human papilloma virus inhibition by a hairpin ribozyme' [patent_app_type] => 1 [patent_app_number] => 8/410005 [patent_app_country] => US [patent_app_date] => 1995-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 6991 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683902.pdf [firstpage_image] =>[orig_patent_app_number] => 410005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477846 [patent_doc_number] => 06451603 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Ribozyme nucleic acids and methods of use thereof for controlling viral pathogens' [patent_app_type] => B1 [patent_app_number] => 08/362478 [patent_app_country] => US [patent_app_date] => 1995-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 11875 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451603.pdf [firstpage_image] =>[orig_patent_app_number] => 08362478 [rel_patent_id] =>[rel_patent_doc_number] =>)